Dexerials, Veritas In Silico to Develop High-Speed RNA Structure Analysis Technology

MT Newswires Live

Nov 04, 2025

Veritas In Silico (TYO:130A) and Dexerials (TYO:4980) said they will jointly develop a high-speed and highly accurate spectroscopic method for RNA structure analysis, according to a Tuesday filing on the Tokyo Stock Exchange.

The collaboration follows proof-of-concept studies begun in December 2023 and aims to establish a non-destructive, rapid measurement method within three years. Veritas will design RNA strands and conduct structural analysis, while Dexerials will apply its spectroscopic and data analysis technologies using machine learning.

Veritas said the new method is expected to enhance its ibVIS platform for mRNA-targeted drug discovery and could later be offered commercially for RNA quality control and manufacturing applications.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/news/2580556789"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"2580556789\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/2580556789?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2025-11-04 17:47","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2580556789","market":"fut","top_or_hot":-1,"title":"Dexerials, Veritas In Silico to Develop High-Speed RNA Structure Analysis Technology","media":"MT Newswires Live","content":"<html><body><p> Veritas In Silico (TYO:130A) and Dexerials (TYO:4980) said they will jointly develop a high-speed and highly accurate spectroscopic method for RNA structure analysis, according to a Tuesday filing on the Tokyo Stock Exchange.</p><p>The collaboration follows proof-of-concept studies begun in December 2023 and aims to establish a non-destructive, rapid measurement method within three years. Veritas will design RNA strands and conduct structural analysis, while Dexerials will apply its spectroscopic and data analysis technologies using machine learning.</p><p>Veritas said the new method is expected to enhance its ibVIS platform for mRNA-targeted drug discovery and could later be offered commercially for RNA quality control and manufacturing applications.</p></body></html>","source":"mtnewswires_news","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Dexerials, Veritas In Silico to Develop High-Speed RNA Structure Analysis Technology</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nDexerials, Veritas In Silico to Develop High-Speed RNA Structure Analysis Technology\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1092851196\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/3002d84abbd5ace3c99397c7f95b8d4e);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">MT Newswires Live </p>\n<p class=\"h-time\">2025-11-04 17:47</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<html><body><p> Veritas In Silico (TYO:130A) and Dexerials (TYO:4980) said they will jointly develop a high-speed and highly accurate spectroscopic method for RNA structure analysis, according to a Tuesday filing on the Tokyo Stock Exchange.</p><p>The collaboration follows proof-of-concept studies begun in December 2023 and aims to establish a non-destructive, rapid measurement method within three years. Veritas will design RNA strands and conduct structural analysis, while Dexerials will apply its spectroscopic and data analysis technologies using machine learning.</p><p>Veritas said the new method is expected to enhance its ibVIS platform for mRNA-targeted drug discovery and could later be offered commercially for RNA quality control and manufacturing applications.</p></body></html>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK4588","symbol_name":"碎股","start_time":0,"source_url":"https://www.mtnewswires.com/","article_id":"2580556789","we_media_id":"1092851196","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2580556789","pubTimestamp":1762249645,"columns":[],"sourceInfo":{"source_id":"mtnewswires_news","name":"MT Newswires"},"weMediaInfo":{"media_name":"MT Newswires Live","introduction":"The most recognized names in North America, Europe and Asia rely on MT Newswires to power their applications. Better news, better service, better price.","home_visible":1,"id":"1092851196","head_image":"https://community-static.tradeup.com/news/3002d84abbd5ace3c99397c7f95b8d4e"},"summary":"Veritas In Silico  and Dexerials  said they will jointly develop a high-speed and highly accurate spectroscopic method for RNA structure analysis, according to a Tuesday filing on the Tokyo Stock Exchange.The collaboration follows proof-of-concept studies begun in December 2023 and aims to establish a non-destructive, rapid measurement method within three years. Veritas will design RNA strands and conduct structural analysis, while Dexerials will apply its spectroscopic and data analysis technologies using machine learning.Veritas said the new method is expected to enhance its ibVIS platform for mRNA-targeted drug discovery and could later be offered commercially for RNA quality control and manufacturing applications.","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"BK4588":"碎股","BK4585":"ETF&股票定投概念","BK4505":"高瓴资本持仓","RNA":"Atrium Therapeutics","BK4139":"生物科技"},"translate_title":"Dexerials与Veritas In Silico合作开发高速RNA结构分析技术","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"RNA":1.5},"content_text":"Veritas In Silico (TYO:130A) and Dexerials (TYO:4980) said they will jointly develop a high-speed and highly accurate spectroscopic method for RNA structure analysis, according to a Tuesday filing on the Tokyo Stock Exchange.The collaboration follows proof-of-concept studies begun in December 2023 and aims to establish a non-destructive, rapid measurement method within three years. Veritas will design RNA strands and conduct structural analysis, while Dexerials will apply its spectroscopic and data analysis technologies using machine learning.Veritas said the new method is expected to enhance its ibVIS platform for mRNA-targeted drug discovery and could later be offered commercially for RNA quality control and manufacturing applications.","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"","news_rank":0,"symbols":[],"gpt_button":1,"need_auth":false,"code":"91000000","status":"200"}}}